L-Phenylalaninol

L-Phenylalaninol

SCHEMBL177073

N[C@@H](CO)Cc1ccccc1

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.76
ANPEP P15144 2/20 0.64
SLC6A2 P23975 2/20 0.56
TAAR1 Q96RJ0 2/20 0.56
MAOA P21397 1/20 0.56
SLC6A4 P31645 1/20 0.56
SLC6A3 Q01959 1/20 0.56
SIGMAR1 Q99720 1/20 0.56
CYP2A6 P11509 1/20 0.56
ADORA2A P29274 1/20 0.56
ADORA1 P30542 1/20 0.56
ALPI P09923 1/20 0.56
PKM P14618 1/20 0.56
PTGS1 P23219 1/20 0.56
XIAP P98170 1/20 0.56
SLC7A5 Q01650 1/20 0.56
TRPA1 O75762 1/20 0.56
CYP2D6 P10635 1/20 0.52
LAP3 P28838 3/20 0.52
MMP2 P08253 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
L-Phenylalaninol SCHEMBL2521 1.00 EPHX1 (0.76) EPHX1ANPEPSLC6A2TAAR1MAOA
L-Phenylalaninol SCHEMBL7422483 1.00 EPHX1 (0.76) EPHX1ANPEPSLC6A2TAAR1MAOA
L-Phenylalaninol SCHEMBL81769 1.00 EPHX1 (0.76) EPHX1ANPEPSLC6A2TAAR1MAOA
L-Phenylalaninol SCHEMBL87692 1.00 EPHX1 (0.76) EPHX1ANPEPSLC6A2TAAR1MAOA
L-Phenylalaninol SCHEMBL31229492 0.98 EPHX1 (0.73) EPHX1ANPEPSLC6A2TAAR1MAOA
L-Phenylalaninol SCHEMBL15467495 0.98 EPHX1 (0.73) EPHX1ANPEPSLC6A2TAAR1MAOA
L-Phenylalaninol SCHEMBL7252746 0.98 EPHX1 (0.73) EPHX1ANPEPSLC6A2TAAR1MAOA
L-Phenylalaninol SCHEMBL30996912 0.98 EPHX1 (0.73) EPHX1ANPEPSLC6A2TAAR1MAOA
L-Phenylalaninol SCHEMBL27430394 0.98 EPHX1 (0.73) EPHX1ANPEPSLC6A2TAAR1MAOA
L-Phenylalaninol SCHEMBL27521331 0.98 EPHX1 (0.73) EPHX1ANPEPSLC6A2TAAR1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1300 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688731-A1 PROCESS FOR PREPARING (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE INKE, S.A. (ES) 2026-02-11 EP claimed
CN-119552185-A Method for recycling 4-BMA from 4-BMA mother liquor recycling material by using chiral amine 济南大学 2025-03-04 CN claimed
WO-2025019172-A1 ANTIMICROBIAL EXTRACTANT FORMED FROM COPPER-CONTAINING SOURCE CORNING INCORPORATED (US) 2025-01-23 WO claimed
EP-4232428-B1 NOVEL PROCESS FOR PREPARING SOLRIAMFETOL HYDROCHLORIDE PROCOS SPA (IT) 2024-11-13 EP claimed
WO-2024208791-A1 PROCESS FOR PREPARING (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE INKE, S.A. (ES) 2024-10-10 WO claimed
US-20230391715-A1 NOVEL PROCESS FOR PREPARING SOLRIAMFETOL HYDROCHLORIDE PROCOS S.P.A. (IT) 2023-12-07 US claimed
CN-117165542-A Engineered beta-amino alcohol dehydrogenase and its use in chiral (R) -beta-amino alcohol preparation 中山大学 2023-12-05 CN claimed
CN-117126896-A Method for preparing (R) -beta-amino alcohol by racemization removal through biological enzyme method 中山大学 2023-11-28 CN claimed
EP-4232428-A1 NOVEL PROCESS FOR PREPARING SOLRIAMFETOL HYDROCHLORIDE Procos S.p.A. (IT) 2023-08-30 EP claimed
CN-114621295-B Chiral oxazoline palladium complex crystal and application thereof 合肥工业大学智能制造技术研究院 2023-08-22 CN claimed
EP-0857790-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS KANEKA CORPORATION (JP) 1998-08-12 EP claimed
CN-1173863-A O -carbamoyl -(D) -phenylalanilol compounds and process for preparing the same YUKONG LTD (KR) 1998-02-18 CN claimed
EP-0815074-A1 O-CARBAMOYL-(D)-PHENYLALANILOL COMPOUNDS AND PROCESS FOR PREPARING THE SAME YUKONG LIMITED (KR) 1998-01-07 EP claimed
CN-1135209-A Novel phenylalkylaminoalcohol carbamates and process for prepn. of same YUKONG LTD (KR) 1996-11-06 CN claimed
EP-0728129-A1 NOVEL PHENYLALKYLAMINOALCOHOL CARBAMATES AND PROCESS FOR PREPARING THE SAME YUKONG LIMITED (KR) 1996-08-28 EP claimed
WO-1996024577-A1 O-CARBAMOYL-(D)-PHENYLALANILOL COMPOUNDS AND PROCESS FOR PREPARING THE SAME YUKONG LIMITED (KR) 1996-08-15 WO claimed
WO-1996007637-A1 NOVEL PHENYLALKYLAMINOALCOHOL CARBAMATES AND PROCESS FOR PREPARING THE SAME YUKONG LIMITED (KR) 1996-03-14 WO claimed
EP-0507534-B1 Succinic acid compounds KISSEI PHARMACEUTICAL (JP) 1996-02-28 EP claimed
US-5440062-A One-(substituted)amino-7-(substituted)imino-1,3,5-cycloheptatriene-metal complexes as catalysts MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1995-08-08 US claimed
WO-1989010916-A1 ENANTIOSELECTIVE ADDITION OF HYDROCARBONS TO ALPHA,BETA-UNSATURATED CARBONYL COMPOUNDS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1989-11-16 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230391715-A1 NOVEL PROCESS FOR PREPARING SOLRIAMFETOL HYDROCHLORIDE KIT, PHYKPL, MYOF EPHX1 377/4885ANPEP 2459/4885SLC6A2 1055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.